Arrowhead Presents New ARO-HBV Clinical Data Demonstrating HBsAg Reductions at World Gastroenterologists Summit
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
Go back to Arrowhead Presents New ARO-HBV Clinical Data Demonstrating HBsAg Reductions at World Gastroenterologists Summit
September 6, 2018 10:44 AM EDT
Arrowhead Pharmaceuticals Corp (NASDAQ: ARWR) adds to early gains following data. Shares are now up 57%.
...
More